Diagnostics group DiaSorin's nine-month adjusted core profit up 6%
Nov 5 (Reuters) - Italian medical diagnostics group DiaSorin DIAS.MI on Tuesday posted a 6% jump in nine-month adjusted core profit to 292 million euros ($318.46 million) at constant exchange rates, driven by its immunodiagnostic segment. ($1 = 0.9169 euros) (Reporting by Michela Stasio in Gdansk Editing by David Goodman ) ((michela.stasio@thomsonreuters.com))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest